Jim Simons Timber Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.24 - $0.39 $205,302 - $333,617
-855,429 Reduced 98.19%
15,808 $5,000
Q1 2022

May 13, 2022
BUY
$0.28 - $0.41 $66,825 - $97,851
238,663 Added 37.73%
871,237 $335,000
Q4 2021

Feb 11, 2022
BUY
$0.38 - $0.89 $240,378 - $562,990
632,574 New
632,574 $240,000
Q3 2021

Nov 12, 2021
SELL
$0.89 - $1.18 $105,736 - $140,189
-118,805 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$1.06 - $2.25 $125,933 - $267,311
118,805 New
118,805 $145,000

About Timber Pharmaceuticals, Inc.

TMBR Quotes by TradingView
  • Ticker TMBR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,524,992
  • Description
  • Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...
More about TMBR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email